The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called aromatic L-amino acid decarboxylase (AADC) deficiency.

Researchers from the Champalimaud Foundation have shed light on the puzzling relationship between dopamine and rest tremor in ...

Enhanced Cognitive Performance: Vyvamind is designed to serve as a potent neurostimulant, utilizing a precise blend of ...